NDC 0006-5055

LAGEVRIO

Molnupiravir

LAGEVRIO is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Merck Sharp & Dohme Llc. The primary component is Molnupiravir.

• Product ID: 0006-5055_12940f6d-e61c-47aa-810e-8b2ad5ce3059
• NDC: 0006-5055
• Product Type: Human Prescription Drug
• Proprietary Name: LAGEVRIO
• Generic Name: Molnupiravir
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2021-12-23
• Marketing Category: EMERGENCY USE AUTHORIZATION /
• Labeler Name: Merck Sharp & Dohme LLC
• Substance Name: MOLNUPIRAVIR
• Active Ingredient Strength: 200 mg/1
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0006-5055-06

40 CAPSULE in 1 BOTTLE, PLASTIC (0006-5055-06)

• Marketing Start Date: 2021-12-23
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details